Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 320

1.

The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder.

Palis H, Marchand K, Karamouzian M, MacDonald S, Harrison S, Guh D, Lock K, Brissette S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E.

Addict Behav Rep. 2018 Mar 27;7:82-89. doi: 10.1016/j.abrep.2018.03.005. eCollection 2018 Jun.

2.

Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.

Bansback N, Guh D, Oviedo-Joekes E, Brissette S, Harrison S, Janmohamed A, Krausz M, MacDonald S, Marsh DC, Schechter MT, Anis AH.

Addiction. 2018 Jul;113(7):1264-1273. doi: 10.1111/add.14171. Epub 2018 Mar 28.

PMID:
29589873
3.

Cango Lyec (Healing the Elephant): Gender Differences in HIV Infection in Post-conflict Northern Uganda.

Spittal PM, Malamba SS, Ogwang MD, Musisi S, Ekwaru JP, Sewankambo NK, Pearce ME, Jongbloed K, Patel SH, Katamba A, Blair AH, Muyinda H, Schechter MT.

J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):257-268. doi: 10.1097/QAI.0000000000001671.

4.

Ethnicity and HIV vulnerabilities among men who have sex with men in China.

Pan SW, Carpiano RM, Li D, Zhang Z, Schechter MT, Spittal PM, Ruan Y.

AIDS Care. 2018 Aug;30(8):1025-1030. doi: 10.1080/09540121.2018.1428727. Epub 2018 Jan 30.

PMID:
29382213
5.

The Cedar Project: mortality among young Indigenous people who use drugs in British Columbia.

Jongbloed K, Pearce ME, Pooyak S, Zamar D, Thomas V, Demerais L, Christian WM, Henderson E, Sharma R, Blair AH, Yoshida EM, Schechter MT, Spittal PM; Cedar Project Partnership.

CMAJ. 2017 Nov 6;189(44):E1352-E1359. doi: 10.1503/cmaj.160778.

6.

Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence.

Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT.

Drug Alcohol Rev. 2018 Jan;37(1):137-146. doi: 10.1111/dar.12573. Epub 2017 Jun 8.

PMID:
28593748
7.

Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.

Palis H, Marchand K, Guh D, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E.

Subst Abuse Treat Prev Policy. 2017 May 19;12(1):25. doi: 10.1186/s13011-017-0110-9.

8.

Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.

Oviedo-Joekes E, Brissette S, MacDonald S, Guh D, Marchand K, Jutha S, Harrison S, Janmohamed A, Zhang DZ, Anis AH, Krausz M, Marsh DC, Schechter MT.

Drug Alcohol Depend. 2017 Jul 1;176:55-62. doi: 10.1016/j.drugalcdep.2017.02.021. Epub 2017 May 10.

PMID:
28521199
9.

The Role of Gender in Suicidal Ideation among Long-term Opioid Users.

Marchand K, Palis H, Fikowski J, Harrison S, Spittal P, Schechter MT, Oviedo-Joekes E.

Can J Psychiatry. 2017 Jul;62(7):465-472. doi: 10.1177/0706743717711173. Epub 2017 May 18.

10.

The Alcohol Use Disorders Identification Test (AUDIT): Exploring the Factor Structure and Cutoff Thresholds in a Representative Post-Conflict Population in Northern Uganda.

Blair AH, Pearce ME, Katamba A, Malamba SS, Muyinda H, Schechter MT, Spittal PM.

Alcohol Alcohol. 2017 May 1;52(3):318-327. doi: 10.1093/alcalc/agw090.

PMID:
28003244
11.

"The Cango Lyec Project - Healing the Elephant": HIV related vulnerabilities of post-conflict affected populations aged 13-49 years living in three Mid-Northern Uganda districts.

Malamba SS, Muyinda H, Spittal PM, Ekwaru JP, Kiwanuka N, Ogwang MD, Odong P, Kitandwe PK, Katamba A, Jongbloed K, Sewankambo NK, Kinyanda E, Blair A, Schechter MT.

BMC Infect Dis. 2016 Nov 21;16(1):690.

12.

Religion and HIV Sexual Risk Among Men Who Have Sex With Men in China.

Pan SW, Zhang Z, Li D, Carpiano RM, Schechter MT, Ruan Y, Spittal PM.

J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):463-474.

PMID:
27391388
13.

Factors Associated with Perceived Abuse in the Health Care System Among Long-Term Opioid Users: A Cross-Sectional Study.

Palis H, Marchand K, Peng D, Fikowski J, Harrison S, Spittal P, Schechter MT, Oviedo-Joekes E.

Subst Use Misuse. 2016 May 11;51(6):763-76. doi: 10.3109/10826084.2016.1155605. Epub 2016 Apr 20.

PMID:
27096889
14.

Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial.

Oviedo-Joekes E, Guh D, Brissette S, Marchand K, MacDonald S, Lock K, Harrison S, Janmohamed A, Anis AH, Krausz M, Marsh DC, Schechter MT.

JAMA Psychiatry. 2016 May 1;73(5):447-55. doi: 10.1001/jamapsychiatry.2016.0109.

PMID:
27049826
15.

The Cedar Project WelTel mHealth intervention for HIV prevention in young Indigenous people who use illicit drugs: study protocol for a randomized controlled trial.

Jongbloed K, Friedman AJ, Pearce ME, Van Der Kop ML, Thomas V, Demerais L, Pooyak S, Schechter MT, Lester RT, Spittal PM; Cedar Project Partnership.

Trials. 2016 Mar 9;17(1):128. doi: 10.1186/s13063-016-1250-3.

16.

Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.

Kinloch NN, MacMillan DR, Le AQ, Cotton LA, Bangsberg DR, Buchbinder S, Carrington M, Fuchs J, Harrigan PR, Koblin B, Kushel M, Markowitz M, Mayer K, Milloy MJ, Schechter MT, Wagner T, Walker BD, Carlson JM, Poon AF, Brumme ZL.

J Virol. 2015 Nov 11;90(3):1244-58. doi: 10.1128/JVI.02353-15. Print 2016 Feb 1.

17.

The Cedar Project: resilience in the face of HIV vulnerability within a cohort study involving young Indigenous people who use drugs in three Canadian cities.

Pearce ME, Jongbloed KA, Richardson CG, Henderson EW, Pooyak SD, Oviedo-Joekes E, Christian WM, Schechter MT, Spittal PM; Cedar Project Partnership.

BMC Public Health. 2015 Oct 29;15:1095. doi: 10.1186/s12889-015-2417-7.

18.

The Cedar Project: Negative health outcomes associated with involvement in the child welfare system among young Indigenous people who use injection and non-injection drugs in two Canadian cities.

Cedar Project Partnership, Clarkson AF, Christian WM, Pearce ME, Jongbloed KA, Caron NR, Teegee MP, Moniruzzaman A, Schechter MT, Spittal PM.

Can J Public Health. 2015 May 7;106(5):e265-70. doi: 10.17269/cjph.106.5026.

PMID:
26451986
19.

The Role of Gender in Factors Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users.

Marchand K, Palis H, Peng D, Fikowski J, Harrison S, Spittal P, Schechter MT, Oviedo-Joekes E.

J Addict Med. 2015 Sep-Oct;9(5):391-8. doi: 10.1097/ADM.0000000000000145.

20.

Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction†.

Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter MT, Lintzeris N, Bell J, Pirona A, Oviedo-Joekes E, Simon R, Metrebian N.

Br J Psychiatry. 2015 Jul;207(1):5-14. doi: 10.1192/bjp.bp.114.149195. Review.

21.

Drug users should be able to get heroin from the health system.

Schechter MT.

BMJ. 2015 Apr 14;350:h1753. doi: 10.1136/bmj.h1753. No abstract available.

PMID:
25873413
22.

The Cedar Project: Residential transience and HIV vulnerability among young Aboriginal people who use drugs.

Jongbloed K, Thomas V, Pearce ME, Christian KW, Zhang H, Oviedo-Joekes E, Schechter MT, Spittal PM; Cedar Project Partnership.

Health Place. 2015 May;33:125-31. doi: 10.1016/j.healthplace.2015.02.008. Epub 2015 Apr 2.

PMID:
25840350
23.

The Cedar Project * : historical trauma and vulnerability to sexual assault among young aboriginal women who use illicit drugs in two Canadian cities.

Pearce ME, Blair AH, Teegee M, Pan SW, Thomas V, Zhang H, Schechter MT, Spittal PM.

Violence Against Women. 2015 Mar;21(3):313-29. doi: 10.1177/1077801214568356. Epub 2015 Feb 3.

PMID:
25648945
24.

The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency.

Oviedo-Joekes E, Marchand K, Lock K, MacDonald S, Guh D, Schechter MT.

Subst Abuse Treat Prev Policy. 2015 Jan 26;10:3. doi: 10.1186/1747-597X-10-3.

25.

Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence.

Oviedo-Joekes E, Sordo L, Guh D, Marsh DC, Lock K, Brissette S, Anis AH, Schechter MT.

Addict Behav. 2015 Feb;41:81-6. doi: 10.1016/j.addbeh.2014.10.003. Epub 2014 Oct 7.

26.

A chance to stop and breathe: participants' experiences in the North American Opiate Medication Initiative clinical trial.

Oviedo-Joekes E, Marchand K, Lock K, Chettiar J, Marsh DC, Brissette S, Anis AH, Schechter MT.

Addict Sci Clin Pract. 2014 Sep 29;9:21. doi: 10.1186/1940-0640-9-21.

27.

Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment.

Oviedo-Joekes E, Guh D, Marchand K, Marsh DC, Lock K, Brissette S, Anis AH, Schechter MT.

Subst Abuse Treat Prev Policy. 2014 Jun 8;9:23. doi: 10.1186/1747-597X-9-23.

28.

Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.

Cotton LA, Kuang XT, Le AQ, Carlson JM, Chan B, Chopera DR, Brumme CJ, Markle TJ, Martin E, Shahid A, Anmole G, Mwimanzi P, Nassab P, Penney KA, Rahman MA, Milloy MJ, Schechter MT, Markowitz M, Carrington M, Walker BD, Wagner T, Buchbinder S, Fuchs J, Koblin B, Mayer KH, Harrigan PR, Brockman MA, Poon AF, Brumme ZL.

PLoS Genet. 2014 Apr 24;10(4):e1004295. doi: 10.1371/journal.pgen.1004295. eCollection 2014 Apr.

29.

Lost in transition: HIV prevalence and correlates of infection among young people living in post-emergency phase transit camps in Gulu District, Northern Uganda.

Patel S, Schechter MT, Sewankambo NK, Atim S, Kiwanuka N, Spittal PM.

PLoS One. 2014 Feb 28;9(2):e89786. doi: 10.1371/journal.pone.0089786. eCollection 2014.

30.

War and HIV: sex and gender differences in risk behaviour among young men and women in post-conflict Gulu District, Northern Uganda.

Patel S, Schechter MT, Sewankambo NK, Atim S, Lakor S, Kiwanuka N, Spittal PM.

Glob Public Health. 2014;9(3):325-41. doi: 10.1080/17441692.2014.887136. Epub 2014 Feb 28.

PMID:
24580099
31.

Comparison of HIV-related vulnerabilities between former child soldiers and children never abducted by the LRA in northern Uganda.

Patel S, Schechter MT, Sewankambo NK, Atim S, Oboya C, Kiwanuka N, Spittal PM.

Confl Health. 2013 Aug 7;7(1):17. doi: 10.1186/1752-1505-7-17.

32.

The effect of waiting time on pain intensity after elective surgical lumbar discectomy.

Quon JA, Sobolev BG, Levy AR, Fisher CG, Bishop PB, Kopec JA, Dvorak MF, Schechter MT.

Spine J. 2013 Dec;13(12):1736-48. doi: 10.1016/j.spinee.2013.05.038. Epub 2013 Jul 11.

PMID:
23850131
33.

The Cedar Project: impacts of policing among young Aboriginal people who use injection and non-injection drugs in British Columbia, Canada.

Pan SW, Christian CW, Pearce ME, Blair AH, Jongbloed K, Zhang H, Teegee M, Thomas V, Schechter MT, Spittal PM.

Int J Drug Policy. 2013 Sep;24(5):449-59. doi: 10.1016/j.drugpo.2013.04.009. Epub 2013 Jun 2.

PMID:
23731672
34.

The Cedar Project: sexual vulnerabilities among Aboriginal young people involved in illegal drug use in two Canadian cities.

Chavoshi N, Waters S, Moniruzzaman A, Richardson CG, Schechter MT, Spittal PM.

Can J Public Health. 2012 Nov 8;103(6):e413-6.

PMID:
23618018
35.

The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities.

Spittal PM, Pearce ME, Chavoshi N, Christian WM, Moniruzzaman A, Teegee M, Schechter MT.

BMC Public Health. 2012 Aug 9;12:632. doi: 10.1186/1471-2458-12-632.

36.

Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment.

Nosyk B, Guh DP, Bansback NJ, Oviedo-Joekes E, Brissette S, Marsh DC, Meikleham E, Schechter MT, Anis AH.

CMAJ. 2012 Apr 3;184(6):E317-28. doi: 10.1503/cmaj.110669. Epub 2012 Mar 12.

37.

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment.

Marchand K, Oviedo-Joekes E, Guh D, Marsh DC, Brissette S, Schechter MT.

Harm Reduct J. 2012 Jan 25;9:8. doi: 10.1186/1477-7517-9-8.

38.

Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for long-term opioid dependency.

Oviedo-Joekes E, Marsh DC, Guh D, Brissette S, Schechter MT.

J Opioid Manag. 2011 Sep-Oct;7(5):371-6.

PMID:
22165036
39.

Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency.

Marchand KI, Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Schechter MT.

BMC Health Serv Res. 2011 Jul 26;11:174. doi: 10.1186/1472-6963-11-174.

40.

The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people.

Miller CL, Pearce ME, Moniruzzaman A, Thomas V, Christian W, Schechter MT, Spittal PM; Cedar Project Partnership.

CMAJ. 2011 Jul 12;183(10):1147-54. doi: 10.1503/cmaj.101257. Epub 2011 Jun 13.

41.
42.

Health related quality of life trajectories of patients in opioid substitution treatment.

Nosyk B, Guh DP, Sun H, Oviedo-Joekes E, Brissette S, Marsh DC, Schechter MT, Anis AH.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):259-64. doi: 10.1016/j.drugalcdep.2011.04.003. Epub 2011 May 4.

PMID:
21546173
43.

History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.

Oviedo-Joekes E, Marchand K, Guh D, Marsh DC, Brissette S, Krausz M, Anis A, Schechter MT.

Addict Behav. 2011 Jan-Feb;36(1-2):55-60. doi: 10.1016/j.addbeh.2010.08.020. Epub 2010 Sep 19.

PMID:
20855171
44.

Characteristics and response to treatment among Aboriginal people receiving heroin-assisted treatment.

Oviedo-Joekes E, Guh D, Marsh DC, Brissette S, Nosyk B, Krausz M, Anis A, Christian WM, Spittal P, Schechter MT.

Can J Public Health. 2010 May-Jun;101(3):210-2.

PMID:
20737811
45.

Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women.

Oviedo-Joekes E, Guh D, Brissette S, Marchand K, Marsh D, Chettiar J, Nosyk B, Krausz M, Anis A, Schechter MT.

Drug Alcohol Depend. 2010 Sep 1;111(1-2):50-7. doi: 10.1016/j.drugalcdep.2010.03.016. Epub 2010 May 26.

PMID:
20510551
46.

The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study.

Nosyk B, Geller J, Guh DP, Oviedo-Joekes E, Brissette S, Marsh DC, Schechter MT, Anis AH.

Drug Alcohol Depend. 2010 Sep 1;111(1-2):161-5. doi: 10.1016/j.drugalcdep.2010.03.019. Epub 2010 May 26.

PMID:
20510549
47.

Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006.

Nosyk B, Marsh DC, Sun H, Schechter MT, Anis AH.

J Subst Abuse Treat. 2010 Jul;39(1):22-31. doi: 10.1016/j.jsat.2010.03.008. Epub 2010 Apr 24.

PMID:
20418051
48.

Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.

Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Nosyk B, Krausz M, Anis A, Schechter MT.

J Subst Abuse Treat. 2010 Jun;38(4):408-11. doi: 10.1016/j.jsat.2010.03.003. Epub 2010 Mar 31.

PMID:
20359843
49.

The quality of eight health status measures were compared for chronic opioid dependence.

Nosyk B, Sun H, Guh DP, Oviedo-Joekes E, Marsh DC, Brissette S, Schechter MT, Anis AH.

J Clin Epidemiol. 2010 Oct;63(10):1132-44. doi: 10.1016/j.jclinepi.2009.12.003. Epub 2010 Mar 17.

PMID:
20236799
50.

The effect of compensation status on waiting time for elective surgical lumbar discectomy.

Quon JA, Levy AR, Sobolev B, Fisher CG, Kopec JA, Bishop P, Dvorak MF, Schechter MT.

Spine (Phila Pa 1976). 2009 Sep 1;34(19):2052-9. doi: 10.1097/BRS.0b013e3181b2f233.

PMID:
19730213

Supplemental Content

Loading ...
Support Center